Key result
Sirolimus combined with surgery successfully treated spindle cell hemangiomas in a patient with Maffucci syndrome.
Why the study?
Currently there is no medical treatment available for spindle cell hemangioma associated with Maffucci syndrome.
Does sirolimus combined with surgery improve management of spindle cell hemangiomas in a patient with Maffucci syndrome?
Does sirolimus combined with surgery improve management of spindle cell hemangiomas in a patient with Maffucci syndrome?
Sirolimus combined with surgery may be an effective treatment for spindle cell hemangiomas in Maffucci syndrome.
Answers are grounded in this paper and cite their sources.
Sirolimus plus surgery may control Maffucci hemangiomas; leaves open need for controlled trials before adoption.
Maffucci syndrome is a rare genetic disease due to somatic mutation of IDH1 gene. Currently there is no medical treatment available for spindle cell hemangioma associated with this disorder. Here we report successful management of these hemangiomas using sirolimus in combination with surgery.
No takes yet. Share an insight, caveat, or question.
Lekwuttikarn et al. (2019) studied this question. Sirolimus combined with surgery successfully treated spindle cell hemangiomas in a patient with Maffucci syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: